Delivery Order SPE2DR25D1100-SPE2DR26FCS6B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $54,157.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,356.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by November 17, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military...
- The Defense Logistics Agency awarded a delivery order valued at $58,642.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a $18,761.49 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 14, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $38,626.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, represents a non-competitive, competitively awarded transaction under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $59,559.83 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive, firm fixed-price delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,181.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed price, non-set-aside contract was competitively awarded on November 17, 2025, with an ultimate completion date of November 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a delivery order valued at $1,902.96 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on December 5, 2025, with a completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $51,982.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS6BDelivery Order
The Defense Logistics Agency awarded a $78,459.61 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive, non-set-aside procurement for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of branded and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract facilitates distribution to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a primary vendor within the DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78.5k | 12/2/25 |